Search Results - "Bett, John S"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Proteostasis regulation by the ubiquitin system by Bett, John S

    Published in Essays in biochemistry (15-10-2016)
    “…Cells have developed an evolutionary obligation to survey and maintain proteome fidelity and avoid the possible toxic consequences of protein misfolding and…”
    Get more information
    Journal Article
  2. 2

    UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome by Hjerpe, Roland, Bett, John S., Keuss, Matthew J., Solovyova, Alexandra, McWilliams, Thomas G., Johnson, Clare, Sahu, Indrajit, Varghese, Joby, Wood, Nicola, Wightman, Melanie, Osborne, Georgina, Bates, Gillian P., Glickman, Michael H., Trost, Matthias, Knebel, Axel, Marchesi, Francesco, Kurz, Thimo

    Published in Cell (11-08-2016)
    “…Clearance of misfolded and aggregated proteins is central to cell survival. Here, we describe a new pathway for maintaining protein homeostasis mediated by the…”
    Get full text
    Journal Article
  3. 3

    Suppression of protein aggregation by chaperone modification of high molecular weight complexes by LABBADIA, John, NOVOSELOV, Sergey S, BETT, John S, WEISS, Andreas, PAGANETTI, Paolo, BATES, Gillian P, CHEETHAM, Michael E

    Published in Brain (London, England : 1878) (01-04-2012)
    “…Protein misfolding and aggregation are associated with many neurodegenerative diseases, including Huntington's disease. The cellular machinery for maintaining…”
    Get full text
    Journal Article
  4. 4

    The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability by Bett, John S, Ibrahim, Adel F M, Garg, Amit K, Kelly, Van, Pedrioli, Patrick, Rocha, Sonia, Hay, Ronald T

    Published in Biochemical journal (15-04-2013)
    “…HIF1A (hypoxia-inducible factor 1α) is the master regulator of the cellular response to hypoxia and is implicated in cancer progression. Whereas the regulation…”
    Get more information
    Journal Article
  5. 5

    Ubiquitin C-terminal hydrolases cleave isopeptide- and peptide-linked ubiquitin from structured proteins but do not edit ubiquitin homopolymers by Bett, John S, Ritorto, Maria Stella, Ewan, Richard, Jaffray, Ellis G, Virdee, Satpal, Chin, Jason W, Knebel, Axel, Kurz, Thimo, Trost, Matthias, Tatham, Michael H, Hay, Ronald T

    Published in Biochemical journal (15-03-2015)
    “…Modification of proteins with ubiquitin (Ub) occurs through a variety of topologically distinct Ub linkages, including Ube2W-mediated monoubiquitylation of…”
    Get more information
    Journal Article
  6. 6

    The ubiquitin-proteasome reporter GFPu does not accumulate in neurons of the R6/2 transgenic mouse model of Huntington's disease by Bett, John S, Cook, Casey, Petrucelli, Leonard, Bates, Gillian P

    Published in PloS one (08-04-2009)
    “…Impairment of the ubiquitin-proteasome system (UPS) has long been considered an attractive hypothesis to explain the selective dysfunction and death of neurons…”
    Get full text
    Journal Article
  7. 7

    The inherited blindness protein AIPL1 regulates the ubiquitin-like FAT10 pathway by Bett, John S, Kanuga, Naheed, Richet, Emma, Schmidtke, Gunter, Groettrup, Marcus, Cheetham, Michael E, van der Spuy, Jacqueline

    Published in PloS one (07-02-2012)
    “…Mutations in AIPL1 cause the inherited blindness Leber congenital amaurosis (LCA). AIPL1 has previously been shown to interact with NUB1, which facilitates the…”
    Get full text
    Journal Article
  8. 8

    Molecular chaperones and photoreceptor function by Kosmaoglou, Maria, Schwarz, Nele, Bett, John S., Cheetham, Michael E.

    Published in Progress in retinal and eye research (01-07-2008)
    “…Molecular chaperones facilitate and regulate protein conformational change within cells. This encompasses many fundamental cellular processes: including the…”
    Get full text
    Journal Article
  9. 9

    Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGγ as a therapeutic target by Bett, John S., Goellner, Geoffrey M., Woodman, Ben, Pratt, Gregory, Rechsteiner, Martin, Bates, Gillian P.

    Published in Human molecular genetics (01-01-2006)
    “…Huntington's disease (HD) is one of a group of neurodegenerative disorders caused by the pathological expansion of a glutamine tract. A hallmark of these…”
    Get full text
    Journal Article
  10. 10

    The polyubiquitin Ubc gene modulates histone H2A monoubiquitylation in the R6/2 mouse model of Huntington's disease by Bett, John S., Benn, Caroline L., Ryu, Kwon‐Yul, Kopito, Ron R., Bates, Gillian P.

    Published in Journal of cellular and molecular medicine (01-08-2009)
    “…Huntington's disease (HD) is an inherited neurodegenerative disease caused by the expansion of a polyglutamine tract in the protein huntingtin (htt). HD brains…”
    Get full text
    Journal Article
  11. 11

    SiRNA screening to identify ubiquitin and ubiquitin-like system regulators of biological pathways in cultured mammalian cells by Bett, John S, Ibrahim, Adel F M, Garg, Amit K, Rocha, Sonia, Hay, Ronald T

    Published in Journal of visualized experiments (24-05-2014)
    “…Post-translational modification of proteins with ubiquitin and ubiquitin-like molecules (UBLs) is emerging as a dynamic cellular signaling network that…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target by Bett, John S, Goellner, Geoffrey M, Woodman, Ben, Pratt, Gregory, Rechsteiner, Martin, Bates, Gillian P

    Published in Human molecular genetics (01-01-2006)
    “…Huntington's disease (HD) is one of a group of neurodegenerative disorders caused by the pathological expansion of a glutamine tract. A hallmark of these…”
    Get full text
    Journal Article
  15. 15

    Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REG[gamma] as a therapeutic target by Bett, John S, Goellner, Geoffrey M, Woodman, Ben, Pratt, Gregory, Rechsteiner, Martin, Bates, Gillian P

    Published in Human molecular genetics (01-01-2006)
    “…Huntington's disease (HD) is one of a group of neurodegenerative disorders caused by the pathological expansion of a glutamine tract. A hallmark of these…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18